Blood levels of MAPK3 mRNA in patients with depression (i.e., Case) were found significantly elevated by nearly 2 folds compared to those in healthy individuals (i.e., Control) (p < 0.05) (Figure 6). Here, MAPK3 is linked to depressive symptom measurement.